First Eagle Investment Management’s Lifestance Health LFST Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$16.7M Sell
1,562,966
-47,500
-3% -$367K 0.03% 159
2026
Q1
$10.3M Buy
1,610,466
+114,000
+8% +$793K 0.02% 178
2025
Q4
$10.5M Buy
1,496,466
+176,000
+13% +$1.06M 0.02% 160
2025
Q3
$7.26M Buy
1,320,466
+109,500
+9% +$537K 0.01% 210
2025
Q2
$6.26M Buy
1,210,966
+218,800
+22% +$1.31M 0.01% 227
2025
Q1
$6.61M Buy
992,166
+206,500
+26% +$1.57M 0.01% 217
2024
Q4
$5.79M Buy
785,666
+507,826
+183% +$3.64M 0.01% 248
2024
Q3
$1.94M Buy
+277,840
New +$1.67M ﹤0.01% 309

Other funds holding LFST

First Eagle Investment Management's LFST Position: Q2 2026 in Review

First Eagle Investment Management reduced its Lifestance Health (LFST) stake by 2.9% in Q2 2026, selling an estimated $367K and leaving 1,562,966 shares worth $16.7M. The position accounts for 0.03% of the portfolio, ranked #159.

First Eagle Investment Management first reported a position in LFST in Q3 2024 and has held it in 8 quarters since. 287 funds tracked by Wall St. Rank hold LFST as of Q2 2026.

  • First Eagle Investment Management held 1,562,966 shares of Lifestance Health worth $16.7M as of Q2 2026.
  • First Eagle Investment Management sold 47,500 Lifestance Health shares in Q2 2026, an estimated $367K.
  • Lifestance Health made up 0.03% of First Eagle Investment Management's portfolio in Q2 2026, its #159 holding.
  • First Eagle Investment Management first reported a position in Lifestance Health in Q3 2024 and has held it in 8 quarters since.
  • 287 funds tracked by Wall St. Rank held Lifestance Health as of Q2 2026.

Based on First Eagle Investment Management's 13F filing for Q2 2026, filed 5 Aug 2026.